搜索期刊名称或人工推荐 均能查询

EXPERT OPINION ON EMERGING DRUGS

SCIE
EXPERT OPINION ON EMERGING DRUGS
杂志名称:关于新兴药物的专家意见
简称:EXPERT OPIN EMERG DR
期刊ISSN:1472-8214
大类研究方向:医学
影响因子:3.23
数据库类型:SCIE
是否OA:No
出版地:ENGLAND
年文章数:28
小类研究方向:药学
审稿速度:>12周,或约稿
平均录用比例:较易

EXPERT OPINION ON EMERGING DRUGS

英文简介

Expert Opinion on Emerging Drugs provides an expert assessment of the most rapidly advancing drug classes and therapeutic areas. Emerging Drugs profiles, prepared by leading experts, are authoritative, comprehensive and up-to date. Expert Opinion on Emerging Drugs is essential reading for pharmaceutical and academic scientists, research planners, pharmaceutical product mangers, clinical opinion leaders and healthcare planners. Expert Opinion on Emerging Drugs was devised with the intention of providing an expert evaluation of the most important emerging drug technologies. These are assessed in terms of their potential impact on the current management of specific diseases. Expert Opinion on Emerging Drugs also includes papers on Emerging Drug Development Strategies, which aim to provide an accessible and independent assessment of the commercial and technical viability of the most promising areas of drug research.

EXPERT OPINION ON EMERGING DRUGS

中文简介

关于新兴药物的专家意见提供了最快速发展的药物类别和治疗领域的专家评估。由主要专家编写的新兴药物简介是权威的、全面的和最新的。新兴药物的专家意见是必不可少的阅读医药和学术科学家,研究规划,医药产品经理,临床意见领袖和医疗保健规划。制定关于新兴药物的专家意见的目的是对最重要的新兴药物技术提供专家评价。这些评估是根据它们对当前特定疾病管理的潜在影响。关于新兴药物的专家意见还包括关于新兴药物发展战略的论文,其目的是对最有希望的药物研究领域的商业和技术可行性提供一种可获得和独立的评估。

EXPERT OPINION ON EMERGING DRUGS

中科院分区(请以最新为准)
大类学科 分区 小类学科 分区 Top期刊 综述期刊
医学 2区 PHARMACOLOGY & PHARMACY 药学 2区

EXPERT OPINION ON EMERGING DRUGS

JCR分区(请以最新为准)
JCR分区等级 JCR所属学科 分区 影响因子
Q2 PHARMACOLOGY & PHARMACY Q2 3.912

EXPERT OPINION ON EMERGING DRUGS

中科院JCR分区历年趋势图

EXPERT OPINION ON EMERGING DRUGS

影响因子

审稿高效 录用率高的SCI、SSCI期刊推荐

填写需求
联系方式
注:学术顾问会在1小时内联系您,请留意!
同类领域发论文期刊推荐

精选同类领域期刊,免费推荐轻松get~

SCI期刊分类

Academic journals
期刊分区查询